Tizanidine Tablet
Product Images NDC 50090-2078

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-2078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01

Chemical structure of Tizanidine Hydrochloride, showing its molecular configuration with chlorine and heterocyclic nitrogen and sulfur atoms.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02

A pharmacokinetic line graph showing plasma tizanidine concentration (ng/mL) over time (hours) from dosing. It compares 4 mg tizanidine tablets and capsules taken with and without food, depicting the concentration changes from 0 to 24 hours post-dose.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03

A line graph showing improvement in Ashworth Score over 6 hours post-dose for Tizanidine 16 mg, 8 mg, and placebo groups. The y-axis represents improvement in Ashworth Score, and the x-axis shows hours post-dose from 0 to 6. The graph compares the effects of two Tizanidine doses against placebo over time.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04

A line graph plotting improvement in Ashworth Score over time at three study points: end of titration (week 3), end of maintenance (week 7), and endpoint (last observation carried forward). It compares two groups: tizanidine (mean dose 28.8 mg) and placebo. The vertical axis shows improvement scores, with tizanidine consistently showing greater improvement than placebo, including error bars at each time point.*

FDA Label Image

Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05

FDA Label Image

Label Image (Lbl500902078)

Tizanidine 2 mg oral tablets packaging label from A-S Medication Solutions. The label includes the product number 5443-0, lot number, and quantity of 30 tablets. Storage instructions specify storing at 40°F to 77°F. The label also notes that each tablet contains 2 mg of tizanidine hydrochloride equivalent to 2 mg tizanidine base.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.